Regional Health Properties, Inc RHE
We take great care to ensure that the data presented and summarized in this overview for REGIONAL HEALTH PROPERTIES, INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding RHE
View all-
Vanguard Group Inc Valley Forge, PA17KShares$44,1220.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.01KShares$2,6360.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY958Shares$2,4900.0% of portfolio
-
Ahrens Investment Partners LLC671Shares$1,7440.0% of portfolio
-
Bartlett & Co. Wealth Management LLC Cincinnati, OH137Shares$3560.0% of portfolio
-
Bartlett & Co. LLC137Shares$3560.0% of portfolio
-
Ubs Group Ag51Shares$1320.0% of portfolio
-
Bank Of America Corp Charlotte, NC15Shares$390.0% of portfolio
-
Citigroup Inc1Shares$20.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
Latest Institutional Activity in RHE
Top Purchases
Top Sells
About RHE
Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. The company's facilities provide a range of healthcare services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term and short-stay patients and residents. As of December 31, 2021, it owned, leased, or managed 24 facilities primarily in the Southeastern United States of America. The company was incorporated in 1991 and is headquartered in Suwanee, Georgia.
Insider Transactions at RHE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 19
2024
|
Brent Morrison CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+22.72%
|
-
|
|
Jun 19
2024
|
Paul Jason O'Sullivan Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+22.68%
|
-
|
|
Aug 30
2023
|
Brent Morrison CEO and President |
BUY
Open market or private purchase
|
Indirect |
1,020
+30.98%
|
$2,040
$2.75 P/Share
|
|
Aug 29
2023
|
Brent Morrison CEO and President |
BUY
Open market or private purchase
|
Indirect |
37
+2.87%
|
$74
$2.71 P/Share
|
|
Aug 28
2023
|
Brent Morrison CEO and President |
BUY
Open market or private purchase
|
Indirect |
268
+18.07%
|
$536
$2.75 P/Share
|
|
Aug 25
2023
|
Brent Morrison CEO and President |
BUY
Open market or private purchase
|
Indirect |
947
+50.0%
|
$1,894
$2.66 P/Share
|
|
Aug 25
2023
|
Paul Jason O'Sullivan Senior Vice President |
BUY
Open market or private purchase
|
Indirect |
1,000
+6.9%
|
$2,000
$2.69 P/Share
|
|
Aug 24
2023
|
Paul Jason O'Sullivan Senior Vice President |
BUY
Open market or private purchase
|
Indirect |
2,500
+16.67%
|
$5,000
$2.81 P/Share
|
|
Jan 17
2023
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,294
+1.5%
|
$21,882
$3.27 P/Share
|
|
Jan 12
2023
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
700
+0.15%
|
$2,100
$3.1 P/Share
|
|
Dec 30
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,606
+2.2%
|
$31,818
$3.0 P/Share
|
|
Dec 29
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,400
+0.95%
|
$8,800
$2.76 P/Share
|
|
Dec 28
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,900
+0.63%
|
$5,800
$2.87 P/Share
|
|
Dec 27
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,158
+1.34%
|
$12,316
$2.79 P/Share
|
|
Dec 23
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,700
+0.38%
|
$3,400
$2.31 P/Share
|
|
Dec 13
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,280
+1.82%
|
$16,560
$2.0 P/Share
|
|
Dec 08
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,182
+3.14%
|
$14,182
$1.7 P/Share
|
|
Dec 07
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,000
+1.4%
|
$6,000
$1.65 P/Share
|
|
Dec 06
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,200
+1.7%
|
$7,200
$1.65 P/Share
|
|
Dec 02
2022
|
Charles L Frischer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,272
+2.9%
|
$12,272
$1.67 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 40K shares |
|---|---|
| Open market or private purchase | 5.77K shares |